SEC Form 4 · accession 0001553878-16-000061
ALNYLAM PHARMACEUTICALS, INC. · ALNY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry E Greene
Officer — President
Period of report
Dec 1, 2016
Accepted (ET)
Dec 5, 2016 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178670
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2016 | M | 55,605 | $22.75 | A | 120,409 | D | |
| Common StockF2 | Dec 1, 2016 | S | 14,349 | $42.6054 | D | 106,060 | D | |
| Common StockF3 | Dec 1, 2016 | S | 16,976 | $43.2815 | D | 89,084 | D | |
| Common StockF4 | Dec 1, 2016 | S | 500 | $44.072 | D | 88,584 | D | |
| Common StockF5 | holding | — | — | — | 2,712 | I | By Managed Account |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F6,F1 | $22.75 | Dec 1, 2016 | M | 55,605 | D | — | Dec 14, 2016 | Common Stock | 55,605 | 0 | D |
Explanation of responses
- F1All sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 6, 2016. The 31,825 options exercised and sold and the 23,780 options exercised and held by the reporting person were due to expire on December 14, 2016.
- F2Sale prices ranged from $42.00 to $42.99.
- F3Sale prices ranged from $43.00 to $43.92.
- F4Sale prices ranged from $44.00 to $44.13.
- F5The reporting person owns 2,712 shares of ALNY common stock under the ALNY 401(k) plan as a result of the ALNY 401(k) matching contribution program.
- F6The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.